The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

Trump’s White House press office did not return requests for comment about the outages. President Trump issued an executive ...

This number is rapidly increasing due to the current outbreak in the Indian states of Maharashtra and Telangana, for which the U.S. Centers for Disease Control and Prevention (CDC ... in Brazil and ...

The global US healthcare environmental services market, valued at US$ 6,317.3 million in 2023, is forecasted to grow at a ...

Cigarette Manufacturing in the US - Industry Market Research Report" report has been added to ResearchAndMarkets.com's offering.This report covers the scope, size, disposition and growth of the ...

Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...

The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the ...

The Centers for Disease Control and Prevention says the flu has been spreading faster than normal. Which states have been hit ...

Cancer and accidental deaths continue to remain the second and third leading causes of death, respectively, according to the latest data from the Centers for Disease Control and Prevention (CDC).

Norovirus outbreaks — most common from November to April — have reached one of their highest levels in the past 12 years, according to data from the Centers for Disease Control and Prevention.